EMA Authorised: Vafseo (vadadustat) — Medice Arzneimittel Pütter GmbH & Co. KG

View source ↗

Summary

EMA authorises Vafseo (vadadustat) for renal insufficiency with anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Anemia
• Renal Insufficiency Chronic

Drugs mentioned

• VAFSEO (VADADUSTAT)

Snippet

Status: Authorised. Therapeutic area: Renal Insufficiency, Chronic;Anemia. MAH: Medice Arzneimittel Pütter GmbH & Co. KG. Decision date: 12/08/2026